Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 11, 2015 - Issue
Submit an article Journal homepage
69
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy

Yukiko Tanamachi1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Junji Saruwatari1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanCorrespondence[email protected]
,
Madoka Noai1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Ryoko Kamihashi1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Hiromi Soraoka1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Yuki Yoshimori1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Naoki Ogusu1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Kentaro Oniki1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
,
Norio Yasui-Furukori2 Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan
,
Takateru Ishitsu3 Kumamoto Saishunso National Hospital, Koshi, Japan;4 Kumamoto Ezuko Ryoiku Iryo Center, Kumamoto, Japan
&
Kazuko Nakagawa1 Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan;5 Center for Clinical Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
 show all
Pages 1007-1014 | Published online: 07 Apr 2015

References

  • MelvilleCAHamiltonSHankeyCRMillerSBoyleSThe prevalence and determinants of obesity in adults with intellectual disabilitiesObes Rev20078322323017444964
  • MaianoCPrevalence and risk factors of overweight and obesity among children and adolescents with intellectual disabilitiesObes Rev201112318919720406413
  • StancliffeRJLakinKCLarsonSOverweight and obesity among adults with intellectual disabilities who use intellectual disability/developmental disability services in 20 U.S. StatesAm J Intellect Dev Disabil2011116640141822126656
  • BegarieJMaianoCLecontePNinotGThe prevalence and determinants of overweight and obesity among French youths and adults with intellectual disabilities attending special education schoolsRes Dev Disabil20133451417142523474994
  • SlevinETruesdale-KennedyMMcConkeyRLivingstoneBFlemingPObesity and overweight in intellectual and non-intellectually disabled childrenJ Intellect Disabil Res201458321122022957929
  • BergATLangfittJTTestaFMGlobal cognitive function in children with epilepsy: a community-based studyEpilepsia200849460861418070088
  • RantanenKErikssonKNieminenPCognitive impairment in preschool children with epilepsyEpilepsia20115281499150521569019
  • ParkJYumMSChoiHWKimEHKimHWKoTSDeterminants of intelligence in childhood-onset epilepsy: a single-center studyEpilepsy Behav201329116617123973641
  • ReillyCAtkinsonPDasKBNeurobehavioral comorbidities in children with active epilepsy: a population-based studyPediatrics20141336e1586e159324864167
  • NanauRMNeumanMGAdverse drug reactions induced by valproic acidClin Biochem201346151323133823792104
  • VerrottiAD’EgidioCMohnACoppolaGChiarelliFWeight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implicationsObes Rev2011125e32e4320880119
  • BelcastroVD’EgidioCStrianoPVerrottiAMetabolic and endocrine effects of valproic acid chronic treatmentEpilepsy Res20131071–21824076030
  • RauchenzaunerMLaimerMWiedmannMThe novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep?Epilepsy Res2013104328528823182413
  • BergATBerkovicSFBrodieMJRevised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia201051467668520196795
  • ColeTJBellizziMCFlegalKMDietzWHEstablishing a standard definition for child overweight and obesity worldwide: international surveyBMJ200032072441240124310797032
  • Ben-MenachemEWeight issues for people with epilepsy – a reviewEpilepsia200748Suppl 9424518047602
  • VerrottiAMancoRAgostinelliSCoppolaGChiarelliFThe metabolic syndrome in overweight epileptic patients treated with valproic acidEpilepsia201051226827319682024
  • LakhanpalDKaurGValproic acid alters GnRH-GABA interactions in cycling female ratsCell Mol Neurobiol20072781069108317823865
  • EggerJBrettEMEffects of sodium valproate in 100 children with special reference to weightBMJ198128362915775816790086
  • ZengKWangXXiZYanYAdverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patientsClin Neurol Neurosurg2010112429129520071075
  • GaspariCNGuerreiroCAModification in body weight associated with antiepileptic drugsArq Neuropsiquiatr201068227728120464300
  • AryaRAnandVGargSKMichaelBDClobazam monotherapy for partial-onset or generalized-onset seizuresCochrane Database Syst Rev201410CD00925825280512
  • AlvarezNBesagFIivanainenMUse of antiepileptic drugs in the treatment of epilepsy in people with intellectual disabilityJ Intellect Disabil Res199842suppl 111510030426
  • Raspall-ChaureMNevilleBGScottRCThe medical management of the epilepsies in children: conceptual and practical considerationsLancet Neurol200871576918093563
  • WassenaarMLeijtenFSEgbertsTCMoonsKGUijlSGPrognostic factors for medically intractable epilepsy: a systematic reviewEpilepsy Res2013106330131023880113
  • GuerriniRRosatiASegiethJPellacaniSBradshawKGiorgiLA randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsyEpilepsia20135481473148023837461
  • CrossJHAuvinSPattenAGiorgiLSafety and tolerability of zonisamide in paediatric patients with epilepsyEur J Paediatr Neurol201418674775825128350
  • DepnerCMStothardERWrightKPJrMetabolic consequences of sleep and circadian disordersCurr Diab Rep201414750724816752
  • VaessenTJOvereemSSitskoornMMCognitive complaints in obstructive sleep apneaSleep Med Rev201519515824846772

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.